Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an unspecified monoclonal antibody therapy for patients with refractory anaplastic large cell lymphoma or Hodgkin lymphoma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Lymphoma | Phase 1 | Status: COMPLETED